The medtech industry has been rising for weeks and the latest seven-day stretch was no exception as stocks ticked up again. MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished last week (Aug. 6) at 119.41 points, marking a 0.5% rise from the previous week’s tally of 118.86 […]
Asensus Surgical
Asensus Surgical reports mixed Q2 results
Asensus Surgical (NYSE American: ASXC) reported second-quarter results that beat the Wall Street earnings consensus forecast but missed on revenue. The Research Triangle Park, N.C.–based surgical robotics company reported a loss of –$13.2 million, or –6¢ per common share, off revenue of $1.1 million for the quarter ended June 30, 2021 — versus a loss […]
FDA clears articulating instruments for Asensus Surgical’s robotic system
Asensus Surgical (NYSE American: ASXC) announced today that FDA has cleared 5 mm diameter articulating instruments for the company’s Senhance surgical system. The instruments previously received a CE mark in the EU. They provide better access to difficult-to-reach areas of the anatomy by providing two additional degrees of freedom. “Bringing the benefits of 5 mm […]
Swiss hospital to begin program with Asensus’ Senhance robotic surgical system
Asensus Surgical (NYSE:ASXC) announced today that a Swiss hospital initiated a program with the Senhance robotic surgical system. Inselspital, University Hospital Bern, Switzerland initiated its Senhance surgical system program, marking the second of two new agreements with two European hospitals in 2021, according to a news release. The university’s department of visceral surgery is implementing […]
Asensus Surgical posts Q1 earnings beat
Asensus Surgical (NYSE:ASXC) shares are down today — a day after the company posted Q1 results that edged the consensus earnings forecast. The Research Triangle Park, N.C.-based robotic surgery company — formerly known as TransEnterix — posted losses of -$17.3 million, or -8¢ per share, on sales of $2.1 million for the three months ended […]
MedTech 100 roundup: Industry rebounds from massive dip
The medtech industry saw its largest fall in several months last week, but it has rebounded slightly after a couple of bad weeks. A strong start to 2021 hit a skid at the end of February and carried over into March, with MassDevice‘s MedTech 100 index hitting its lowest point on March 8 (102.16). It had […]
Asensus Surgical rises on Street-beating Q4
Asensus Surgical (NYSE:ASXC) shares ticked up before hours today on fourth-quarter results that topped the consensus forecast. The Research Triangle Park-based robotic surgery company, which recently changed its name from TransEnterix, posted losses of –$13.8 million, or –13¢ per share, on sales of $1.1 million for the three months ended Dec. 31, 2020, for a nearly […]
MedTech 100 roundup: Industry sees largest fall since October
The medtech industry’s hot start to 2021 has finally come to a full halt after stocks fell harder than they had in more than four months. MassDevice‘s MedTech 100 index ended the week (March 5) at 103.3 points, marking a -3.1% dip from the 106.65-point mark set one week before (Feb. 26). In less than a […]
DTW Podcast: Can AI, advanced imaging and robotics ‘democratize’ surgery?
A new generation of digital surgery systems will level surgeons’ playing field — giving them artificial intelligence, robotic tools, and other assistive technologies. In three interviews in this week’s DeviceTalks Weekly Podcast, leaders from Asensus, ActivSurgical and Memic explain how their systems will improve surgeon performance, reduce errors, and deliver the “democratization” of surgical robotics. […]
Asensus Surgical finalizes name change from TransEnterix, debuts NYSE ticker
Asensus Surgical (NYSE:ASXC) announced today that it formally completed its name and stock ticker change from TransEnterix (NYSE:TRXC). Research Park Triangle, N.C.-based Asensus announced last month that the company would change its name from TransEnterix to Asensus Surgical and introduce a new surgery category. The company aims to enter a new era of performance-guided surgery […]
Asensus Surgical wins FDA nod for general surgery with Senhance robotic surgery system
Asensus Surgical (NYSE:TRXC), formerly TransEnterix, announced that it won expanded FDA clearance for its Senhance surgical system. Research Triangle Park, N.C.–based Asensus Surgical’s Senhance surgical system, which it touts as the first-of-its-kind digital laparoscopic platform that leverages augmented intelligence to provide strong performance and positive patient outcomes through machine learning, now has FDA clearance for […]